SevenBridge Financial »

Xilio Therapeutics shares owned by SevenBridge Financial

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by SevenBridge Financial from 13F filings

Historical chart of SevenBridge Financial investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by SevenBridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by SevenBridge Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $37k 31k 1.18

More positions owned by SevenBridge Financial

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Pepsi (PEP)
NVIDIA Corporation (NVDA)
Hershey Company (HSY)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Exxon Mobil Corporation (XOM)

View all positions for SevenBridge Financial

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
FMR
RiverVest Venture Management
Rock Springs Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Fil
Geode Capital Management
Bridgeway Capital Management
Millennium Management
BlackRock
SevenBridge Financial
PFG Investments

View all funds holding Xilio Therapeutics